Considering the role of Nrf-2 in cancerous cells, particularly the responsibility of Nrf-2 activation in the development of chemoresistance inactivating drug-mediated oxidative stress that normally leads cancer cells to death [17,18,19], these results may also have important clinical implications in cancer research. The gene discussed is NFE2L2; the disease is cancer.